Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.020
+0.021 (2.10%)
Aug 14, 2025, 1:52 PM - Market open
Coherus Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 179.75 | 28.51 | -237.89 | -291.75 | -287.1 | 132.24 | Upgrade
|
| Depreciation & Amortization | 4.64 | 5.28 | 3.79 | 3.7 | 3.45 | 2.89 | Upgrade
|
| Other Amortization | 4.16 | 4.16 | 2.41 | 6.43 | 4.26 | 3.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | -176.59 | -176.59 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 10.57 | - | - | 3.21 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 1.1 | - | Upgrade
|
| Stock-Based Compensation | 24.05 | 27.8 | 43.11 | 50.74 | 51.36 | 38.16 | Upgrade
|
| Other Operating Activities | 39.28 | 23.94 | 50.53 | 69.02 | 143.93 | 12.02 | Upgrade
|
| Change in Accounts Receivable | 170.29 | 149.35 | -150.68 | 13.05 | 34.06 | -15.22 | Upgrade
|
| Change in Inventory | -31.87 | -31.95 | -46.73 | -47.35 | -6.25 | -38.36 | Upgrade
|
| Change in Accounts Payable | -43.18 | -3.94 | 23.76 | -4.55 | 0.87 | -9.82 | Upgrade
|
| Change in Other Net Operating Assets | -115.03 | -57.57 | 136.83 | -40.41 | 13.68 | 28.75 | Upgrade
|
| Operating Cash Flow | -105.87 | -20.44 | -174.88 | -241.12 | -37.43 | 154.15 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | 443.63% | Upgrade
|
| Capital Expenditures | - | - | - | - | -1.29 | -7.23 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.18 | Upgrade
|
| Cash Acquisitions | - | - | 7 | - | - | - | Upgrade
|
| Divestitures | 227.82 | 227.82 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -12.5 | -12.5 | - | -35 | - | -7.5 | Upgrade
|
| Investment in Securities | -20.73 | 14.89 | 138.14 | -127.38 | -1.12 | 0.16 | Upgrade
|
| Other Investing Activities | 250.46 | 0.11 | -0.49 | -4.47 | -136 | - | Upgrade
|
| Investing Cash Flow | 445.05 | 230.32 | 144.64 | -166.85 | -138.41 | -14.4 | Upgrade
|
| Long-Term Debt Issued | - | 36.98 | - | 240.68 | - | 222.16 | Upgrade
|
| Long-Term Debt Repaid | - | -260.39 | - | -190.75 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -233.33 | -223.41 | - | 49.93 | - | 222.16 | Upgrade
|
| Issuance of Common Stock | 0.72 | 2.67 | 74.22 | 9.37 | 54.3 | 21.23 | Upgrade
|
| Repurchase of Common Stock | -0.3 | -2.48 | -3.59 | -3.74 | -1.75 | -0.88 | Upgrade
|
| Other Financing Activities | -48.82 | 36.24 | -1.03 | -1.23 | -0.67 | -18.56 | Upgrade
|
| Financing Cash Flow | -281.72 | -186.97 | 69.6 | 54.33 | 51.88 | 223.95 | Upgrade
|
| Net Cash Flow | 57.46 | 22.91 | 39.36 | -353.65 | -123.96 | 363.69 | Upgrade
|
| Free Cash Flow | -105.87 | -20.44 | -174.88 | -241.12 | -38.72 | 146.91 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 453.70% | Upgrade
|
| Free Cash Flow Margin | -38.89% | -7.66% | -67.98% | -114.25% | -11.86% | 30.88% | Upgrade
|
| Free Cash Flow Per Share | -0.91 | -0.18 | -1.86 | -3.11 | -0.51 | 1.76 | Upgrade
|
| Cash Interest Paid | 25.38 | 25.38 | 37.86 | 34.88 | 18.68 | 16.96 | Upgrade
|
| Cash Income Tax Paid | - | -0.11 | -0.12 | 0.04 | 1.22 | 3.95 | Upgrade
|
| Levered Free Cash Flow | 9.2 | 41.59 | -69.86 | -186.86 | -60.97 | 83.04 | Upgrade
|
| Unlevered Free Cash Flow | 20.3 | 54.4 | -46.93 | -173 | -50.88 | 92.78 | Upgrade
|
| Change in Working Capital | -19.79 | 55.89 | -36.83 | -79.26 | 42.36 | -34.65 | Upgrade
|
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.